HK1089666A1 - Composition for administration of iron for the treatment of restless legs syndrome - Google Patents

Composition for administration of iron for the treatment of restless legs syndrome

Info

Publication number
HK1089666A1
HK1089666A1 HK06110065.3A HK06110065A HK1089666A1 HK 1089666 A1 HK1089666 A1 HK 1089666A1 HK 06110065 A HK06110065 A HK 06110065A HK 1089666 A1 HK1089666 A1 HK 1089666A1
Authority
HK
Hong Kong
Prior art keywords
iron
administration
treatment
composition
restless legs
Prior art date
Application number
HK06110065.3A
Other languages
English (en)
Inventor
Mary Jane Helenek
Ralf A Lange
Fred B Oldham
Marc L Tokars
Original Assignee
Vifor Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vifor Int Ag filed Critical Vifor Int Ag
Publication of HK1089666A1 publication Critical patent/HK1089666A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines Containing Plant Substances (AREA)
HK06110065.3A 2003-03-14 2006-09-11 Composition for administration of iron for the treatment of restless legs syndrome HK1089666A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/389,228 US6960571B2 (en) 2003-03-14 2003-03-14 Methods and compositions for administration of iron for the treatment of restless leg syndrome
PCT/US2003/015087 WO2004082693A1 (en) 2003-03-14 2003-05-13 Composition for administration of iron for the treatment of restless legs syndrome

Publications (1)

Publication Number Publication Date
HK1089666A1 true HK1089666A1 (en) 2006-12-08

Family

ID=32962229

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06110065.3A HK1089666A1 (en) 2003-03-14 2006-09-11 Composition for administration of iron for the treatment of restless legs syndrome

Country Status (26)

Country Link
US (1) US6960571B2 (xx)
EP (1) EP1603580B1 (xx)
JP (2) JP2006520322A (xx)
KR (1) KR100978377B1 (xx)
CN (1) CN1771044B (xx)
AT (1) ATE400280T1 (xx)
AU (1) AU2003249635C1 (xx)
BR (1) BR0318185A (xx)
CA (1) CA2518971C (xx)
CY (1) CY1110407T1 (xx)
DE (1) DE60322121D1 (xx)
DK (1) DK1603580T3 (xx)
ES (1) ES2309403T3 (xx)
HK (1) HK1089666A1 (xx)
HR (1) HRP20050796A2 (xx)
IL (1) IL170386A (xx)
MX (1) MXPA05009786A (xx)
NO (1) NO20054728L (xx)
PL (1) PL206810B1 (xx)
PT (1) PT1603580E (xx)
RS (1) RS51823B (xx)
RU (1) RU2319490C2 (xx)
SI (1) SI1603580T1 (xx)
UA (1) UA83483C2 (xx)
WO (1) WO2004082693A1 (xx)
ZA (1) ZA200508308B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10249552A1 (de) * 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060116349A1 (en) * 2003-03-14 2006-06-01 Luitpold Pharmaceuticals, Inc. Methods and compositions for administration of iron for the treatment of restless leg syndrome
EP1655040A1 (en) * 2004-10-08 2006-05-10 Bracco Imaging, S.P.A. Contrast agent formulations for the visualization of the lymphatic system
EP1790356A1 (de) * 2005-11-24 2007-05-30 Vifor (International) Ag Präparat, umfassend Eisen(III)-Komplexverbindungen und redoxaktive Substanz(en)
JP2009520023A (ja) * 2005-12-20 2009-05-21 セリュウサイエンス エイビー 下肢静止不能症候群を治療及び診断するための方法及び組成物
BRPI0620425B8 (pt) * 2005-12-23 2021-06-22 Gupta Ajay composição para nutrição parenteral, método para preparar a mesma, uso, e, kit
KR101905340B1 (ko) 2006-01-06 2018-10-05 루이트폴드 파머수티컬스, 인코퍼레이티드 철을 투여하기 위한 방법 및 조성물
AU2013206429B2 (en) * 2006-01-06 2016-04-28 Vifor (International) Ag Methods and compositions for administration of iron
AU2016205002C1 (en) * 2006-01-06 2020-09-24 Vifor (International) Ag Methods and compositions for administration of iron
US20080132465A1 (en) * 2006-12-05 2008-06-05 Vincent Windisch Apparatus and method for isolating iron components from serum
EP1941869A1 (en) * 2007-01-04 2008-07-09 Vifor (International) Ag Multicompartment bag for storage of iron preparations
EP2265113B1 (en) * 2008-03-28 2014-07-16 Chyna Llc Use of ferritin to treat iron deficiency disorders
WO2009143439A1 (en) * 2008-05-23 2009-11-26 Hospira, Inc. Packaged iron sucrose products
EP2356130A4 (en) * 2008-11-06 2012-05-02 Biotie Therapies Ag TREATMENT OF NON-REST LEG SYNDROME AND OTHER SLEEP DISORDERS
HUE030866T2 (en) 2009-03-25 2017-06-28 Pharmacosmos Holding As Stable iron-oligosaccharide compound
US8058076B2 (en) * 2009-03-31 2011-11-15 Astron Research Limited In-vitro method for testing bioequivalence of iron-sucrose formulation
CN102440999A (zh) * 2010-10-15 2012-05-09 天津瑞普生物技术股份有限公司 一种用于防治仔猪缺铁性贫血、低过敏反应的复方药物
WO2012104204A1 (en) 2011-01-31 2012-08-09 Vifor (International) Ag Iron-carbohydrate complex compounds for the intravenous therapy of malaria
CA2904357C (en) 2013-03-15 2020-09-22 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof
JP2014132029A (ja) * 2014-04-03 2014-07-17 Chyna Llc 鉄欠乏性障害を治療するためのフェリチンの使用
NZ730186A (en) 2014-09-22 2020-04-24 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
US20170304367A1 (en) * 2014-10-29 2017-10-26 University Of Utah Research Foundation Methods of treating hypoxia-associated optical conditions with cartilage oligo matrix protein-angiopoietin 1 (comp-ang1)
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US5248492A (en) 1986-07-03 1993-09-28 Advanced Magnetics, Inc. Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
US5700832A (en) * 1994-10-19 1997-12-23 Daewon Pharm. Co., Ltd. Antianemic agent containing iron and difructose
SE9803760D0 (sv) 1998-11-04 1998-11-04 Jan Hedner Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel
US6611707B1 (en) * 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
AU2001251306A1 (en) 2000-04-04 2001-10-15 Siegel, Jerome M. Treatment of sleep disorders with hypocretin-1

Also Published As

Publication number Publication date
RS51823B (sr) 2012-02-29
SI1603580T1 (sl) 2009-04-30
CY1110407T1 (el) 2015-04-29
RU2319490C2 (ru) 2008-03-20
US20040180849A1 (en) 2004-09-16
WO2004082693A1 (en) 2004-09-30
AU2003249635B2 (en) 2009-06-04
ES2309403T3 (es) 2008-12-16
NO20054728L (no) 2005-12-13
AU2003249635C1 (en) 2009-11-05
PL378875A1 (pl) 2006-05-29
PL206810B1 (pl) 2010-09-30
EP1603580B1 (en) 2008-07-09
ZA200508308B (en) 2006-10-25
CN1771044B (zh) 2012-09-19
JP2006520322A (ja) 2006-09-07
CN1771044A (zh) 2006-05-10
DK1603580T3 (da) 2008-10-06
KR100978377B1 (ko) 2010-08-30
PT1603580E (pt) 2008-09-10
RU2005131832A (ru) 2006-03-20
IL170386A (en) 2013-03-24
MXPA05009786A (es) 2006-03-08
EP1603580A1 (en) 2005-12-14
ATE400280T1 (de) 2008-07-15
CA2518971C (en) 2009-02-17
JP2010180252A (ja) 2010-08-19
NO20054728D0 (no) 2005-10-13
AU2003249635A1 (en) 2004-10-11
KR20060082032A (ko) 2006-07-14
US6960571B2 (en) 2005-11-01
HRP20050796A2 (en) 2005-12-31
UA83483C2 (uk) 2008-07-25
BR0318185A (pt) 2006-03-21
CA2518971A1 (en) 2004-09-30
DE60322121D1 (de) 2008-08-21
RS20050695A (xx) 2008-04-04

Similar Documents

Publication Publication Date Title
HK1089666A1 (en) Composition for administration of iron for the treatment of restless legs syndrome
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
HRP20041071A2 (en) Methods of treating hepatitis
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
HK1197656A1 (zh) 糖原累積病 型的療法
SG146643A1 (en) Treating or preventing restless legs syndrome using prodrugs of gaba analogs
HK1086186A1 (en) Use of spongosine (2-methoxyadenosein) for preparing pharmaceutical for the treatment of pain
MXPA02002681A (es) Uso de metabolitos de acido alfa-linolenico para el tratamiento o prevencion del cancer.
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
WO2007055804A3 (en) Methods and compositions for administration of iron for the treatment of restless leg syndrome
UA72927C2 (uk) Композиція для лікування печінково-клітинного раку, що містить доцетаксель
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
PL372313A1 (en) Method for producing pseudo islets
UA50328A (uk) Спосіб лікування атоній передшлунків великої рогатої худоби
MD994G2 (ro) Metodă de corecţie a secreţiei gastrice acide în patologia gastrointestinală
UA42532A (uk) Спосіб лікування сальмонельозного менінгіту тифімуріум у дітей раннього віку
UA49213A (uk) Спосіб лікування передчасного телархе
UA34199A (uk) Спосіб лікування пародонтиту
UA42427A (uk) Спосіб корекції целюліту та/або локальних жирових відкладень

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20160513